X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Gland Pharma Ltd.
BSE CODE: 543245   |   NSE CODE: GLAND   |   ISIN CODE : INE068V01023   |   03-Nov-2025 Hrs IST
BSE NSE
Rs. 1972.15
42.65 ( 2.21% )
 
Prev Close ( Rs.)
1929.50
Open ( Rs.)
1947.95
 
High ( Rs.)
2030.00
Low ( Rs.)
1925.00
 
Volume
14300
Week Avg.Volume
4646
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1972.00
43.1 ( 2.23% )
 
Prev Close ( Rs.)
1928.90
Open ( Rs.)
1942.70
 
High ( Rs.)
2034.00
Low ( Rs.)
1922.60
 
Volume
330511
Week Avg.Volume
192957
 
52 WK High-Low Range(Rs.)
1277.8
2131
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)66.14  63.34  47.11  73.78  60.95  
   CEPS(Rs)76.42  73.19  56.01  80.49  66.98  
   DPS(Rs)18.00  20.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)592.08  546.04  482.79  434.87  359.30  
   Tax Rate(%)25.64  25.77  26.00  25.13  25.31  
Margin Ratios          
   Core EBITDA Margin(%)35.05  33.80  28.16  34.33  37.61  
   EBIT Margin(%)36.16  33.91  29.19  36.91  38.65  
   Pre Tax Margin(%)35.61  33.73  28.99  36.79  38.55  
   PAT Margin (%)26.48  25.04  21.45  27.54  28.79  
   Cash Profit Margin (%)30.59  28.93  25.51  30.05  31.64  
Performance Ratios          
   ROA(%)10.92  11.39  9.34  16.92  18.84  
   ROE(%)11.62  12.31  10.28  18.62  20.97  
   ROCE(%)15.87  16.67  13.97  24.86  28.00  
   Asset Turnover(x)0.41  0.46  0.44  0.61  0.65  
   Sales/Fixed Asset(x)1.53  1.71  1.65  2.51  2.49  
   Working Capital/Sales(x)0.79  1.00  0.59  0.84  0.75  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.65  0.58  0.61  0.40  0.40  
   Receivable days102.61  89.08  97.78  72.40  67.08  
   Inventory Days111.48  140.38  158.00  102.05  107.06  
   Payable days70.34  87.29  113.93  74.33  96.62  
Valuation Parameters          
   PER(x)24.07  29.08  26.93  44.31  40.66  
   PCE(x)20.84  25.17  22.65  40.62  36.99  
   Price/Book(x)2.69  3.37  2.63  7.52  6.90  
   Yield(%)1.13  1.09  0.00  0.00  0.00  
   EV/Net Sales(x)5.78  6.90  4.74  11.51  10.84  
   EV/Core EBITDA(x)14.36  18.24  13.61  29.19  26.12  
   EV/EBIT(x)15.99  20.34  16.23  31.17  28.05  
   EV/CE(x)2.44  3.19  2.15  7.07  5.78  
   M Cap / Sales6.37  7.28  5.78  12.21  11.71  
Growth Ratio          
   Net Sales Growth(%)-1.23  15.23  -17.82  27.08  31.51  
   Core EBITDA Growth(%)5.22  25.13  -27.42  20.70  31.28  
   EBIT Growth(%)5.31  33.86  -35.00  21.37  33.82  
   PAT Growth(%)4.45  34.48  -36.00  21.58  29.00  
   EPS Growth(%)4.42  34.47  -36.15  21.05  22.19  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)11.01  11.04  9.43  10.04  10.00  
   Quick Ratio(x)8.62  7.99  6.77  8.01  7.51  
   Interest Cover(x)65.18  180.20  142.41  309.98  392.34  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00